| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.65B | 23.56B | 23.32B | 21.65B | 22.28B | 21.60B |
| Gross Profit | 4.44B | 4.41B | 4.27B | 3.82B | 3.74B | 3.98B |
| EBITDA | 2.27B | 2.39B | 2.08B | 1.64B | 1.71B | 1.98B |
| Net Income | 1.23B | 1.28B | 1.32B | 962.35M | 947.99M | 1.10B |
Balance Sheet | ||||||
| Total Assets | 33.97B | 36.92B | 33.43B | 33.49B | 30.35B | 29.40B |
| Cash, Cash Equivalents and Short-Term Investments | 9.16B | 9.64B | 8.94B | 8.45B | 8.15B | 8.05B |
| Total Debt | 1.20B | 1.20B | 1.21B | 1.24B | 1.29B | 1.13B |
| Total Liabilities | 9.51B | 9.44B | 9.16B | 9.69B | 9.09B | 9.32B |
| Stockholders Equity | 23.64B | 26.71B | 23.45B | 23.05B | 20.49B | 19.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.10B | 984.18M | 336.73M | 174.92M | 729.41M |
| Operating Cash Flow | 0.00 | 2.09B | 1.97B | 992.48M | 773.83M | 1.84B |
| Investing Cash Flow | 0.00 | -1.27B | -2.29B | -700.43M | -773.19M | -1.16B |
| Financing Cash Flow | 0.00 | -375.50M | -326.97M | -240.99M | -38.25M | -201.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥142.96B | 6.66 | 10.46% | 2.35% | 2.55% | 72.25% | |
76 Outperform | ¥584.59B | 9.78 | 6.90% | 2.71% | 4.41% | 176.65% | |
74 Outperform | ¥78.43B | 21.16 | ― | 6.64% | 2.45% | 1.87% | |
70 Outperform | ¥13.19B | 10.20 | ― | 1.20% | 1.06% | -1.71% | |
69 Neutral | ¥63.18B | 15.41 | ― | 3.31% | 2.25% | 30.32% | |
63 Neutral | ¥97.18B | 12.05 | 7.53% | 3.01% | 5.17% | 20.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |